The effect of induction pegylated interferon alfa 2b and ribavirin on early virologic response in genotype 1 chronic hepatitis C

被引：0
|
作者：
Lawitz, EJ
Harrison, SA
Cantu, NS
Davis, M
Perkel, M
Vemuru, R
Nguyen, T
Kadakia, S
Ganeshappa, KP
Diamond, K
Matossian, H
Box, TD
Ghandour, E
机构：
来源：
GASTROENTEROLOGY | 2004年 / 126卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A723 / A723
页数：1
相关论文
共 50 条
  • [31] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    PN Rao
    Abraham Koshy
    Jacob Philip
    Narayanan Premaletha
    Joy Varghese
    Krishnasamy Narayanasamy
    Samir Mohindra
    Nitin Vikas Pai
    Manoj Kumar Agarwal
    Ashokna Konar
    Hasmukh B Vora
    World Journal of Hepatology, 2014, (07) : 520 - 526
  • [32] Comparison of early virologic response among patients with chronic hepatitis C infected with genotype non 2/3 treated with pegylated interferon alfa-2b and ribavirin in dependence with hepatic fibrosis stages
    Berak, H.
    Kolakowska-Rzqdzka, A.
    Wasilewski, M.
    Kowalska, J.
    Stanczak, J. J.
    Bardadin, K.
    Horban, A.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S218 - S218
  • [33] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    Rao, P. N.
    Koshy, Abraham
    Philip, Jacob
    Premaletha, Narayanan
    Varghese, Joy
    Narayanasamy, Krishnasamy
    Mohindra, Samir
    Pai, Nitin Vikas
    Agarwal, Manoj Kumar
    Konar, Ashoknanda
    Vora, Hasmukh B.
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 520 - 526
  • [34] Pegylated interferon alfa 2b and ribavirin for hepatitis C patients who were nonresponders to previous
    Lawitz, EJ
    Bala, NS
    Becker, S
    Brown, G
    Davis, M
    Dhar, R
    Ganeshappa, KP
    Gordon, S
    Holtzmuller, K
    Jeffries, M
    Li, JJ
    Monsour, H
    Nader, P
    Rosenfield, T
    Tolman, K
    Kadakia, S
    GASTROENTEROLOGY, 2003, 124 (04) : A783 - A784
  • [35] Kinetic of Virologic Response to Pegylated Interferon and Ribavirin in Children With Chronic Hepatitis C Predicts the Effect of Treatment
    Indolfi, Giuseppe
    Nebbia, Gabriella
    Cananzi, Mara
    Maccabruni, Anna
    Zaramella, Marco
    D'Antiga, Lorenzo
    Grisotto, Laura
    Azzari, Chiara
    Resti, Massimo
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (12) : 1300 - 1303
  • [36] Induction of Autoimmune Hepatitis by Pegylated Interferon Alfa-2b in Chronic Hepatitis C
    Loerke, Julia
    Erhardt, Andreas
    Haeussinger, Dieter
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (12) : A20 - A20
  • [37] PEGYLATED INTERFERON ALFA-2A VS PEGYLATED INTERFERON ALFA-2B, PLUS RIBAVIRIN, FOR CHRONIC HEPATITIS C GENOTYPE 4 PATIENTS: A RANDOMIZED CONTROLLED TRIAL
    Kamal, Sanaa
    Ghoraba, Dalia
    Nabegh, Leila
    Nasser, Imad
    Motaoe, Mona
    Sayed, Mohamed E.
    Gohary, Iman
    HEPATOLOGY, 2009, 50 (04) : 1025A - 1026A
  • [38] A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
    You, Byung Chul
    Kim, Young Seok
    Kim, Hun il
    Kim, Se Hun
    Park, Seung Sik
    Seo, Yu Ri
    Kim, Sang Gyune
    Lee, Se Whan
    Kim, Hong Soo
    Jeong, Soung Won
    Jang, Jae Young
    Kim, Boo Sung
    CLINICAL AND MOLECULAR HEPATOLOGY, 2012, 18 (03) : 272 - 278
  • [39] De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infection
    Jose L. Tovar
    Maria Buti
    Alfonso Segarra
    Joaquim Majó
    Rafael Esteban
    International Urology and Nephrology, 2008, 40 : 539 - 541
  • [40] De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infection
    Tovar, Jose L.
    Buti, Maria
    Segarra, Alfonso
    Majo, Joaquim
    Esteban, Rafael
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2008, 40 (02) : 539 - 541
12345